EVH
Evolent Health, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
+10/100
Last price
3.84
▲ 0.23 (6.37%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
3.61
Prev close
3.61
Day high
3.87
Day low
3.63
Volume
1.59M
Market cap
$434.15M
P/E (TTM)
—
52W range
2.10 – 8.46
Day trading desk
Gap from prior close
+0.00%
Prior close 3.61
VWAP
3.80
+0.99% from price
Relative volume
1.23×
Normal
Session range
7.20%
3.61 – 3.87
Position in range
88%
Near session high
ATR (14D)
0.19
4.95% of price
Prior day high
3.64
PDH
Prior day low
3.44
PDL
Bid / ask spread
—
Quote not published
Session volume
3.67M
Avg 2.97M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+9.09%
+7.1%
1M
-11.11%
-12.3%
3M
-31.43%
-35.9%
6M
+51.18%
+33.0%
YTD
-4.00%
-18.2%
1Y
-53.34%
-69.8%
3Y
-85.90%
-168.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on EVH open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+1.12M
Net buying
Buy transactions
13
1.19M shares
Sell transactions
1
65.89K shares
Net transactions
+14
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
3.51M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 26, 26 | MCCARTHY DANIEL JOSEPH President |
SELL | 65.89K | $329.46K | Direct |
| Jul 1, 26 | BLACKLEY SETH Chief Executive Officer |
STOCK | 446.10K | $0 | Direct |
| Jul 1, 26 | WEINBERG JONATHAN D. General Counsel |
STOCK | 43.05K | $0 | Direct |
| Jul 1, 26 | SHAMS AAMMAAD Officer |
STOCK | 28.79K | $0 | Direct |
| Jul 1, 26 | MCCARTHY DANIEL JOSEPH President |
STOCK | 302.58K | $0 | Direct |
| Jun 4, 26 | GRUA PETER J Director |
STOCK | 41.10K | $0 | Direct |
| Jun 4, 26 | GUERTIN SHAWN M Director |
STOCK | 41.10K | $0 | Direct |
| Jun 4, 26 | JELINEK RICHARD M Director |
STOCK | 41.10K | $0 | Direct |
| Jun 4, 26 | BARBAROSH CRAIG A Director |
STOCK | 41.10K | $0 | Direct |
| Jun 4, 26 | SPRINGSTUBB BRENDAN B. Director |
STOCK | 41.10K | $0 | Direct |
| Jun 4, 26 | KECK KIM Director |
STOCK | 41.10K | $0 | Direct |
| Jun 4, 26 | SMITH JILL D Director |
STOCK | 41.10K | $0 | Direct |
| Jun 4, 26 | AJAYI TOYIN Director |
STOCK | 41.10K | $0 | Direct |
| Jun 4, 26 | GLASS RUSSELL MONROE Director |
STOCK | 41.10K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLACKLEY SETH |
Chief Executive Officer | 1.27M | Stock Award(Grant) |
GRUA PETER J |
Director | 123.74K | Stock Award(Grant) |
JELINEK RICHARD M |
Director | 107.53K | Stock Award(Grant) |
JOHNSON JOHN PAUL |
Chief Financial Officer | 309.25K | Stock Award(Grant) |
KECK KIM |
Director | 102.60K | Stock Award(Grant) |
MCCARTHY DANIEL JOSEPH |
President | 655.13K | Sale |
RAFFERTY EMILY ANN |
Chief Operating Officer | 130.13K | Stock Award(Grant) |
RAMOS MARIO |
Chief Financial Officer | 587.50K | Stock Award(Grant) |
SPRINGSTUBB BRENDAN B. |
Director | 99.92K | Stock Award(Grant) |
WEINBERG JONATHAN D. |
General Counsel | 284.92K | Stock Award(Grant) |
Fundamentals
Market cap$434.15M
Enterprise value$1.29B
Revenue (TTM)$2.10B
Gross profit$361.64M
EBITDA$61.04M
Net income$-511.06M
EPS (TTM)$-4.78
Free cash flow$184.30M
Total cash$115.70M
Total debt$970.43M
Book value / share$3.40
Shares outstanding113.06M
Float94.21M
Short % of float12.58%
Dividend yield0.00%
Beta (5Y)1.02
Valuation & profitability ratios
Trailing P/E—
Forward P/E9.51
PEG ratio1.93
Price / sales—
Price / book1.13
EV / revenue0.62
EV / EBITDA21.12
Gross margin17.24%
Operating margin-1.34%
Profit margin-24.08%
Return on equity-66.97%
Return on assets-0.79%
Debt / equity253.23
Current ratio1.24
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.88B | $2.55B | $1.96B | $1.35B | -26.6% |
| Operating revenue | $1.88B | $2.55B | $1.96B | $1.35B | -26.6% |
| Cost of revenue | $1.48B | $2.19B | $1.50B | $1.04B | -32.5% |
| Gross profit | $399.88M | $367.35M | $460.47M | $316.58M | +8.9% |
| Selling, general & admin | $303.87M | $263.05M | $358.11M | $269.27M | +15.5% |
| Total operating expense | $419.72M | $381.42M | $481.52M | $336.46M | +10.0% |
| Operating income | -$19.83M | -$14.07M | -$21.05M | -$19.88M | -41.0% |
| Net interest income | -$53.28M | -$19.18M | -$48.95M | -$14.20M | -177.8% |
| Pre-tax income | -$534.64M | -$63.04M | -$202.41M | -$62.08M | -748.1% |
| Tax provision | -$126.00K | -$1.41M | -$89.36M | -$43.38M | +91.1% |
| Net income | -$534.51M | -$61.62M | -$113.04M | -$19.16M | -767.4% |
| Net income to common | -$579.40M | -$93.45M | -$142.26M | -$19.16M | -520.0% |
| Basic EPS | -5.07 | -0.81 | -1.28 | -0.20 | -525.9% |
| Diluted EPS | -5.07 | -0.81 | -1.28 | -0.20 | -525.9% |
| EBIT | -$477.17M | -$38.31M | -$148.20M | -$46.51M | -1,145.4% |
| EBITDA | -$361.31M | $80.06M | -$24.79M | $20.69M | -551.3% |
| Basic shares | 114.21M | 114.68M | 111.25M | 93.70M | -0.4% |
| Diluted shares | 114.21M | 114.68M | 111.25M | 93.70M | -0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $151.86M | $104.20M | $192.82M | $188.20M | +45.7% |
| Cash & short-term investments | $151.86M | $104.20M | $192.82M | $188.20M | +45.7% |
| Accounts receivable | $309.86M | $414.68M | $446.75M | $254.68M | -25.3% |
| Total current assets | $506.37M | $607.12M | $683.67M | $478.05M | -16.6% |
| Property, plant & equipment | $85.16M | $79.28M | $90.18M | $136.90M | +7.4% |
| Goodwill & intangibles | $1.28B | $1.82B | $1.87B | $1.17B | -29.6% |
| Total assets | $1.90B | $2.54B | $2.68B | $1.82B | -25.4% |
| Total current liabilities | $385.26M | $715.50M | $674.24M | $433.44M | -46.2% |
| Current debt | — | $171.47M | — | — | — |
| Long-term debt | $970.54M | $490.52M | $597.05M | $412.99M | +97.9% |
| Total debt | $989.70M | $713.67M | $644.80M | $476.12M | +38.7% |
| Total liabilities | $1.48B | $1.54B | $1.61B | $957.88M | -3.8% |
| Retained earnings | -$1.32B | -$780.82M | -$719.19M | -$606.15M | -68.5% |
| Shareholder equity | $415.19M | $1.00B | $1.07B | $859.42M | -58.5% |
| Working capital | $121.11M | -$108.38M | $9.43M | $44.61M | +211.7% |
| Net tangible assets | -$864.23M | -$816.22M | -$800.85M | -$306.14M | -5.9% |
| Shares issued | 117.60M | 116.58M | 115.42M | 101.50M | +0.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$534.51M | -$61.62M | -$113.04M | -$19.16M | -767.4% |
| Depreciation & amortisation | $115.85M | $118.37M | $123.42M | $67.19M | -2.1% |
| Stock-based compensation | $39.74M | $39.75M | $40.50M | $33.98M | -0.0% |
| Change in working capital | -$57.38M | -$116.56M | $21.89M | -$106.94M | +50.8% |
| Operating cash flow | $38.84M | $18.77M | $142.58M | -$11.55M | +107.0% |
| Capital expenditure | -$34.09M | -$24.89M | -$28.75M | -$38.36M | -36.9% |
| Investing cash flow | -$233.00K | -$62.93M | -$415.54M | -$259.12M | +99.6% |
| Share buybacks | -$40.00M | $0 | $0 | — | — |
| Dividends paid | -$11.13M | -$20.09M | -$18.79M | -$14.88M | +44.6% |
| Financing cash flow | -$35.92M | -$565.00K | $281.34M | $131.54M | -6,258.2% |
| Free cash flow | $4.75M | -$6.13M | $113.84M | -$49.91M | +177.6% |
| End cash position | $180.70M | $178.50M | $223.46M | $215.16M | +1.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $652.52M | $496.25M | $468.72M | $479.53M | $444.33M | +31.5% |
| Operating revenue | $652.52M | $496.25M | $468.72M | $479.53M | $444.33M | +31.5% |
| Cost of revenue | $571.68M | $412.47M | $371.47M | $379.76M | $343.94M | +38.6% |
| Gross profit | $80.84M | $83.77M | $97.25M | $99.77M | $100.39M | -3.5% |
| Selling, general & admin | $68.83M | $72.82M | $72.66M | $77.59M | $75.21M | -5.5% |
| Total operating expense | $90.40M | $94.37M | $117.69M | $101.21M | $98.35M | -4.2% |
| Operating income | -$9.56M | -$10.60M | -$20.44M | -$1.43M | $2.04M | +9.8% |
| Net interest income | -$16.16M | -$15.85M | -$18.14M | -$15.51M | -$10.52M | -1.9% |
| Pre-tax income | -$25.65M | -$25.72M | -$430.81M | -$19.96M | -$20.72M | +0.3% |
| Tax provision | $2.71M | $910.00K | -$1.68M | $906.00K | -$825.00K | +198.4% |
| Net income | -$28.36M | -$26.63M | -$429.13M | -$20.86M | -$19.90M | -6.5% |
| Net income to common | -$28.36M | -$26.63M | -$429.13M | -$26.93M | -$51.09M | -6.5% |
| Basic EPS | -0.25 | -0.24 | -3.84 | -0.24 | -0.44 | -4.2% |
| Diluted EPS | -0.25 | -0.24 | -3.84 | -0.24 | -0.44 | -4.2% |
| EBIT | -$11.77M | -$8.85M | -$407.04M | -$5.84M | -$10.37M | -32.9% |
| EBITDA | $9.79M | $12.70M | -$362.00M | $17.77M | $12.77M | -22.9% |
| Basic shares | 112.54M | 111.91M | 111.61M | 114.07M | 115.88M | +0.6% |
| Diluted shares | 112.54M | 111.91M | 111.61M | 114.07M | 115.88M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $115.70M | $142.03M | $151.86M | $116.65M | $151.00M | — | -18.5% |
| Cash & short-term investments | $115.70M | $142.03M | $151.86M | $116.65M | $151.00M | — | -18.5% |
| Accounts receivable | $449.12M | $314.16M | $309.86M | $386.56M | $358.76M | — | +43.0% |
| Total current assets | $610.51M | $502.01M | $506.37M | $570.09M | $562.26M | — | +21.6% |
| Property, plant & equipment | $84.63M | $85.05M | $85.16M | $84.92M | $82.61M | — | -0.5% |
| Goodwill & intangibles | $1.25B | $1.26B | $1.28B | $1.70B | $1.79B | — | -1.2% |
| Total assets | $1.97B | $1.88B | $1.90B | $2.45B | $2.46B | — | +5.0% |
| Total current liabilities | $492.83M | $381.24M | $385.26M | $429.93M | $557.52M | — | +29.3% |
| Current debt | — | — | — | $5.12M | $172.12M | $171.79M | — |
| Long-term debt | $966.47M | $973.49M | $970.54M | $1.05B | $648.46M | — | -0.7% |
| Total debt | $970.43M | $985.42M | $989.70M | $1.08B | $853.19M | — | -1.5% |
| Total liabilities | $1.59B | $1.48B | $1.48B | $1.61B | $1.57B | — | +7.2% |
| Retained earnings | -$1.37B | -$1.34B | -$1.32B | -$886.20M | -$865.33M | — | -2.1% |
| Shareholder equity | $383.22M | $396.39M | $415.19M | $842.23M | $896.00M | — | -3.3% |
| Working capital | $117.68M | $120.78M | $121.11M | $140.17M | $4.74M | — | -2.6% |
| Net tangible assets | -$865.64M | -$867.72M | -$864.23M | -$856.84M | -$892.49M | — | +0.2% |
| Shares issued | 112.68M | 118.45M | 117.60M | 117.56M | 117.47M | — | -4.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$28.36M | -$26.63M | -$429.13M | -$20.86M | -$19.90M | -6.5% |
| Depreciation & amortisation | $21.57M | $21.55M | $45.04M | $23.61M | $23.14M | +0.1% |
| Stock-based compensation | $15.20M | $10.65M | $2.40M | $14.68M | $11.58M | +42.7% |
| Change in working capital | -$25.38M | -$11.53M | $36.46M | -$11.39M | -$59.41M | -120.1% |
| Operating cash flow | -$9.31M | -$984.00K | $48.80M | $15.81M | -$30.33M | -846.3% |
| Capital expenditure | -$6.85M | -$6.41M | -$7.76M | -$8.96M | -$8.77M | -6.9% |
| Investing cash flow | -$6.70M | -$6.41M | $82.15M | -$8.76M | -$60.53M | -4.6% |
| Share buybacks | — | — | $0 | — | — | — |
| Dividends paid | $0 | $0 | $0 | -$1.93M | -$4.62M | — |
| Financing cash flow | -$10.99M | -$3.97M | -$93.04M | -$41.81M | -$8.93M | -176.7% |
| Free cash flow | -$16.16M | -$7.39M | $41.04M | $6.85M | -$39.10M | -118.7% |
| End cash position | $141.47M | $168.74M | $180.70M | $143.00M | $177.97M | -16.2% |
Options analytics
Put / call volume
0.09
Call-heavy session
Put / call open interest
0.08
Positioning, not flow
Max pain
2.50
-34.9% from spot
ATM implied vol
129.7%
Nearest strike to spot
Skew (10% OTM)
+42.2%
Puts bid over calls
Call volume
68
Contracts, this expiry
Put volume
6
Contracts, this expiry
Heaviest call OI
2.50
580 contracts
Heaviest put OI
2.50
50 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.02 | 0.02 | +229.9% |
| Mar 2026 | -0.05 | -0.02 | +57.2% |
| Dec 2025 | 0.05 | 0.08 | +62.7% |
| Sep 2025 | 0.10 | 0.05 | -51.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.06 | 9 | $727.05M | +51.6% |
| Next quarter | 0.15 | 8 | $759.43M | +62.0% |
| Current year | 0.20 | 9 | $2.64B | +40.5% |
| Next year | 0.40 | 9 | $3.30B | +25.1% |
Analyst targets & ownership
Mean target$5.75
High target$8.00
Low target$3.00
Implied upside49.74%
Analyst count12
ConsensusBUY
Strong buy / Buy4 / 7
Hold3
Sell / Strong sell0 / 0
Held by insiders3.10%
Held by institutions101.35%
Institutions holding270
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
3.57
+7.53% from price
SMA 20
3.73
+2.88% from price
SMA 50
3.98
-3.47% from price
SMA 100
4.39
-12.61% from price
SMA 200
3.83
+0.27% from price
EMA 12
3.65
+5.16% from price
EMA 26
3.83
+0.30% from price
EMA 50
4.03
-4.74% from price
RSI (14)
50.0
Neutral
MACD (12,26,9)
-0.18
Hist 0.02
ATR (14)
0.19
4.95% of price
Realised vol 30D
51.3%
Annualised
Bollinger upper
4.21
20, 2σ
Bollinger lower
3.26
20, 2σ
50 / 200 cross
Golden
3.98 vs 3.83
Trend bias
Above 200
+0.27%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.00
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
51.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-73.7%
Peak to trough
Max drawdown 5Y
-94.5%
Peak to trough
ATR 14
0.19
4.95% of price
Beta (reported)
1.02
5Y monthly, from filing
Short interest
Shares short
14.07M
Prior 15.77M
Change vs prior
-10.8%
Shorts covering
% of float
12.58%
Elevated
% of shares out
12.44%
Against total outstanding
Days to cover
5.5
Crowded exit
Float
94.21M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 18, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 17, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Aug 12, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Aug 11, 26 | Citigroup | UPGRADE | Neutral | Buy |
| Aug 10, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 28, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 23, 26 | Citigroup | DOWNGRADE | Buy | Neutral |
| Jul 21, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jun 30, 26 | Truist Securities | DOWNGRADE | Buy | Hold |
| Jun 12, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| May 15, 26 | Citigroup | MAINTAINED | Buy | Buy |
| May 12, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-06
Offering Registrations
S-8 · 2026-06-10
Corporate Changes & Voting Matters
8-K · 2026-06-04
Periodic Financial Reports
10-Q · 2026-05-07
Proxy Statements
DEF 14A · 2026-04-24
Periodic Financial Reports
10-K · 2026-02-25
Corporate Changes & Voting Matters
8-K · 2026-02-24
Offering Registrations
S-8 · 2026-01-02
Headlines
3 Reasons to Avoid EVH and 1 Stock to Buy Instead
StockStory · 15d ago
TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
PR Newswire · 16d ago
TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
GlobeNewswire · 16d ago
Q2 Healthcare Technology for Providers Earnings: Evolent Health (NYSE:EVH) Impresses
StockStory · 20d ago
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Find Risky
StockStory · 25d ago
1 Value Stock with Promising Prospects and 2 That Underwhelm
StockStory · 36d ago
1 Healthcare Stock Worth Your Attention and 2 We Brush Off
StockStory · 52d ago
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call
StockStory · 53d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.